Impossible for foreign enterprises to trademark Vietnamese rice “ST25”: intellectual property office
… because US law does not protect the trademark for the plant variety and as … On November 20, 2020, the US Patent and Trademark Office (USPTO) …
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Peptide Cancer Therapy Market Therapeutics Drug Sales Patent Price USD 20 Billion Opportunity 2026 – PRNewswire
Peptide Cancer Therapy Market Therapeutics Drug Sales Patent Price USD 20 Billion Opportunity 2026 PRNewswire
-
In: PATENT NEWS
The world is desperate for more Covid vaccines – patents shouldn’t get in the way – The Guardian
The world is desperate for more Covid vaccines – patents shouldn’t get in the way The Guardian
-
In: PATENT NEWS
The world is desperate for more Covid vaccines – patents shouldn’t get in the way
The arguments against opening up the rights to make coronavirus vaccines are the same ones the industry has always used: that it would stifle …
-
In: PATENT NEWS
Biotechnological Inventions And Patentability Of Life The Us And European Experience New …
and Trademark OfficeBiotechnology and Intellectual Property RightsPatent Law in Greater ChinaBiopatent Law: Patent Strategies and Patent.
-
In: PATENT NEWS
As pandemic surges anew, global envy and anger over US vaccine abundance
… for policy changes in Washington and a broader rethink of the intellectual property and trademark laws that govern vaccine manufacturing in global …
-
In: PATENT NEWS
There’s no day like World IP Day to prove US innovation is a priority: op-ed
Just recently, NYU law professors estimated that in 2017, 67% of Chinese-originating trademark applications for use on apparel-related products filed in …
-
In: PATENT NEWS
Flaster Greenberg adds patent talent ICLG News – ICLG.com
Flaster Greenberg adds patent talent ICLG News ICLG.com
-
In: PATENT NEWS
When Do My Patents Expire? | Rothwell, Figg, Ernst & Manbeck, PC – JDSupra – JD Supra
When Do My Patents Expire? | Rothwell, Figg, Ernst & Manbeck, PC – JDSupra JD Supra
-
In: PATENT NEWS
Fed. Circ. Won’t Rehear Amgen Drug Patent Fight – Law360
Fed. Circ. Won’t Rehear Amgen Drug Patent Fight Law360